Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia
Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Kyle Davis
,
Amy Shapiro
,
Sanjay Ahuja
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Haemophilia
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1111/hae.70273
Similar Items
Dental Management of Persons With Haemophilia Receiving Emicizumab Prophylaxis
by: Branislav V. Bajkin, et al.
Published: (2026)
Mild Matters: A Survey of US Haematologists on the Diagnosis and Management of Individuals With Mild Haemophilia
by: Ming Y. Lim, et al.
Published: (2025)
Lifetime Cost‐Utility Analysis of Emicizumab Prophylaxis in Severe Haemophilia A Without Inhibitors in China: A Markov Model Analysis
by: Han Bao, et al.
Published: (2026)
Multicentre Retrospective and Prospective Analysis of Data on Emicizumab and Factor VIII Prophylaxis in Children With Severe Haemophilia A: Egypt‐Compare Study
by: Tamer Hassan, et al.
Published: (2026)
Low‐Dose Emicizumab Versus Low‐/Intermediate‐Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype
by: Nuchanun Kessakorn, et al.
Published: (2024)